Skip to content

Clinical trials

Completed Phase 2/3 Leukemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia Phase: Phase 2/3 Status: Completed Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20061
20101
20161
20171
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen1
Ann & Robert H Lurie Children's Hospital of Chicago1
Chimeric Therapies1
Federal Research Institute of Pediatric Hematology, Oncology and Immunology1
Jazz Pharmaceuticals1
Roswell Park Cancer Institute1
The University of New South Wales1
Universitätsklinikum Hamburg-Eppendorf1
Virginia Commonwealth University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia9
Precursor Cell Lymphoblastic Leukemia-Lymphoma6
Leukemia, Myeloid, Acute5
Myelodysplastic Syndromes5
Anemia, Refractory, with Excess of Blasts4
Leukemia, Myeloid, Accelerated Phase3
Leukemia, Myeloid, Chronic-Phase3
Lymphoma3
Neoplasms3
Anemia, Refractory2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.